Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PEARL II: PEripheral Use of AngioJet® Rheolytic Thrombectomy With a Variety of Catheter Lengths

NCT01086215 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT01086215
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01086215 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PEARL II: PEripheral Use of AngioJet® Rheolytic Thrombectomy With a Variety of Catheter Lengths
Lead sponsor
Boston Scientific Corporation
Phase
Observational
Overall status
Completed
Start date
January 31, 2010
Completion date
September 30, 2013
Enrollment
500 (actual)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

embolism and thrombosis, peripheral vascular disease, venous thrombosis